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Abstract
Introduction Tracer delay-sensitive perfusion algorithms in
CT perfusion (CTP) result in an overestimation of the extent
of ischemia in thromboembolic stroke. In diagnosing delayed
cerebral ischemia (DCI) after aneurysmal subarachnoid hem-
orrhage (aSAH), delayed arrival of contrast due to vasospasm
may also overestimate the extent of ischemia. We investigated
the diagnostic accuracy of tracer delay-sensitive and tracer
delay-insensitive algorithms for detecting DCI.
Methods From a prospectively collected series of aSAH pa-
tients admitted between 2007–2011, we included patients with
any clinical deterioration other than rebleeding within 21 days
after SAH who underwent NCCT/CTP/CTA imaging. Causes
of clinical deterioration were categorized into DCI and no
DCI. CTP maps were calculated with tracer delay-sensitive
and tracer delay-insensitive algorithms and were visually
assessed for the presence of perfusion deficits by two inde-
pendent observers with different levels of experience. The
diagnostic value of both algorithms was calculated for both
observers.
Results Seventy-one patients were included. For the experi-
enced observer, the positive predictive values (PPVs) were
0.67 for the delay-sensitive and 0.66 for the delay-
insensitive algorithm, and the negative predictive values
(NPVs) were 0.73 and 0.74. For the less experienced observer,
PPVs were 0.60 for both algorithms, and NPVs were 0.66 for
the delay-sensitive and 0.63 for the delay-insensitive
algorithm.
Conclusion Test characteristics are comparable for tracer
delay-sensitive and tracer delay-insensitive algorithms for
the visual assessment of CTP in diagnosing DCI. This indi-
cates that both algorithms can be used for this purpose.
Keywords Subarachnoid hemorrhage . CT perfusion .
Delayed cerebral ischemia
Introduction
In patients who deteriorate within the first weeks after aneu-
rysmal subarachnoid hemorrhage (aSAH), it can be difficult to
differentiate delayed cerebral ischemia (DCI) from other
causes of deterioration. The use of CT perfusion (CTP) can
be helpful to make this differentiation [1]. Perfusion deficits
on CTP have been associated with DCI in patients with aSAH
[2, 3]. An arterial input function is required to calculate quan-
titative perfusion values with CTP. The arterial input function
can be influenced by pathology of the brain and blood vessels
[4]. Occurrence of delay or dispersion between the site of the
arterial input function selection and the area of perfusion mea-
surement leads to an underestimation of cerebral blood flow
(CBF) and overestimation of the mean transit time (MTT)
when a delay-sensitive method is used [5]. This delay and
dispersion can be caused by blood vessel occlusion or
narrowing and collateral blood supply. In patients with throm-
boembolic stroke, the bias in the estimated perfusion parame-
ters due to the use of tracer delay-sensitive perfusion
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algorithms results in an overestimation of the extent of ische-
mia [5–8]. Similarly, in patients with aSAH, vasospasm may
cause both delayed arrival and dispersion of contrast to certain
regions of the brain. As a result, the presence of vasospasm
could result in overestimation of the extent of DCI when using
tracer delay-sensitive perfusion algorithms. An alternative
method to tracer delay-sensitive perfusion algorithms is a trac-
er delay-insensitive algorithm. These delay-insensitive algo-
rithms correlate well with the final infarct areas in ischemic
stroke patients [7].
The purpose of this study was to compare the diagnostic
accuracy of two CTP algorithms (tracer delay sensitive and
tracer delay insensitive) to differentiate DCI from other causes
of clinical deterioration in aSAH patients.
Materials and methods
Design
Patients were retrieved from a prospectively collected series of
aSAH patients admitted to the University Medical Center
Utrecht between August 2007 and February 2011. In our in-
stitution all patients with aSAH routinely undergo non-
contrast CT (NCCT), CTP, and CT angiography (CTA) at
admission and at any time of clinical deterioration after aSAH,
unless there are contraindications for CTwith contrast, such as
impaired renal function. Inclusion criteria for this study were
as follows: (1) 18 years of age or older, (2) clinical deteriora-
tion other than rebleeding within 21 days after aSAH, and (3)
follow-up imaging (CT or MR) at least 3 days after clinical
deterioration. Patients were excluded in case of movement
artefacts or technical failure preventing proper interpretation
of the CTP scan. The study was approved by the institutional
review board.
Outcome DCI
Causes of clinical deterioration were categorized into DCI and
non-DCI. DCI was defined as a clinical deterioration (new
focal deficit, decreased Glasgow Coma Scale of at least two
points, or both) lasting 1 h or longer with no evidence for
rebleeding or hydrocephalus on CT and no other medical ex-
planation, such as cardiovascular or pulmonary complica-
tions, infections, or metabolic disturbances [9]. The diagnosis
of DCI was made by two observers (CHPC and MDIV) who
were blinded for CTP data. All clinical data, except for CTP
results, were available when evaluating the presence or ab-
sence of DCI. Patients with clinical deterioration who did
not meet the criteria for DCI were included in the non-DCI
group.
CTA and CTP imaging
The imaging studies were performed on a 16-, 64-, or 128-
multidetector CTscanner (PhilipsMx8000 IDT 16, Philips Bril-
liance 16P, Philips Brilliance 64, Philips Brilliance iCT; Best,
The Netherlands). For the CTP scan, 40 mL of non-ionic con-
trast agent (lopromide, Ultravist, 300 mg iodine/mL, Schering,
Berlin, Germany) was injected into the cubital vein (18-gauge
needle) at a rate of 5 mL/s followed by a 40-mL saline flush at a
rate of 5 mL/s using a dual power injector (Stellant Dual CT
injector, Medrad Europe BV, Beek, The Netherlands). The fol-
lowing parameters were used: 16 slice, 90 kVp, 150 mAs, 8×
3 mm collimation; 64 slice, 80 kVp, 150 mAs, 64×0.625 mm
collimation; and 128 slice, 80 kVp, 150 mAs, 128×0.625 mm
collimation. For all scanners, one image was acquired per 2 s
from initiation of contrast injection during 60 s, with a 512×512
matrix, a field of view ranging from 160 to 220 mm, UB filter
and standard resolution. Depending on the multidetector-type
CT scanner, for the CTA scan, another 60–80 mL of contrast
was injected at a rate of 5 mL/s, followed by a 40-mL saline
flush at a rate of 5 mL/s. Imaging was performed with the
following: 80–120 kVp, 150–300 mAs, 512×512 matrix,
160–200-mm field of view, 0.9–1-mm slice thickness, and
0.45–0.5-mm reconstruction increment.
CTP post-processing
All CTP scans were reconstructed to 5-mm slices and corrected
for axial rotation and translation. For noise reduction, a filter
using the time-intensity profile similarity to reduce noise in the
spatial domain was applied [10]. Perfusion data were analyzed
using an open-source software package called Perfusion Mis-
match Analyzer (version 3.4.0.6, ASIST, Japan). The arterial
input functionwas automatically selected by PerfusionMismatch
Analyzer and manually corrected if the automatic selection
failed. An in-house software tool was developed using
MeVisLab (MeVisLab®, software for medical image processing
and visualization; http://www.mevislab.de) for visualization of
the perfusion maps. Two different CTP algorithms were used
to calculate quantitative cerebral perfusion maps for four
different perfusion parameters: CBF, cerebral blood volume
(CBV), MTT, and time-to-peak (TTP). The two algorithms were
(1) first moment MTT and (2) block-circulant singular value
decomposition. The first moment MTT determines the first mo-
ment of the time attenuation curves without using a tissue residue
function and is delay sensitive [11], while block-circulant singu-
lar value decomposition is delay insensitive [12].
CTP evaluation
Anonymized CTP color maps (CBF, CBV,MTT, and TTP)were
visually assessed by two independent observers (JWD and
CHPC). The observers were blinded for any other NCCT, CTP,
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or CTA studies but had knowledge of the patient’s clinical con-
dition (GCS-score and focal deficit if applicable). The first ob-
server (JWD) was an experienced observer of CTP imaging
(6 years experiencewith CTP inDCI), while the second observer
(CHPC) was a less experienced observer (1.5 years experience).
For the second observer, the time between the diagnosing of DCI
based on the clinical definition and the evaluation of theCTPwas
more than 3 months. In every patient, both CTP algorithms were
displayed separately as a collection of the four perfusion maps
(CBF, CBV, MTT, and TTP) and the NCCT. The two different
CTP algorithms were offered randomly to each observer. For
each CTP algorithm, the observers had to first indicate if a per-
fusion deficit was visible on all maps together, and next if it was
visible on every separate CTP map. Positive findings were
hypoperfused areas (lower CBF or CBV or higher MTT or
TTP), indicating some degree of ischemia, that were not local-
ized in the neurosurgical trajectory or directly surrounding an
intracerebral hematoma.
Vasospasm
The degree of vasospasm on CTA was assessed on a Philips
workstation by one observer (JWD) blinded for clinical data
and other imaging studies (except for the admission CTA).
The vessel diameter on the follow-up scan was compared to
the admission scan to assess the presence and degree of vaso-
spasm for the following vessel segments: the proximal and
distal segments of the anterior, middle, and posterior cerebral
artery and basilar artery (A1, A2, M1, M2, P1, and P2 seg-
ments on both sites and basilar artery). Vasospasm was cate-
gorized as none (0–25 % decrease in vessel diameter), mod-
erate (25–50% decrease in vessel diameter), or severe (>50%
decrease in vessel diameter). For each patient, the vessel with
the most severe spasm was noted for subgroup analysis.
Analyses
Sensitivity, specificity, positive predictive value (PPV), and
negative predictive value (NPV) for detection of DCI were
calculated for both CTP algorithms and for both observers.
DCI was diagnosed according to predefined criteria as men-
tioned above and used as the gold standard in our analyses.
Since we hypothesized that vasospasm potentially affected the
results of both CTP algorithms, we performed a subgroup
analysis in which only patients with severe vasospasm were
included. For all test characteristics, we calculated 95 % CIs.
Results
In total, 73 patients met the inclusion criteria. Two patients were
excluded because of insufficient CTP quality due to movement
artefacts. Of the remaining 71 patients, 33 patients had clinical
deterioration due to DCI and 38 patients (non-DCI group) had
clinical deterioration from another cause (Table 1). The distri-
bution of the patients over the different types of scanners (16-,
64-, and 128-detector scanner) was comparable in the DCI
group (12, 55, and 33 %, respectively) and non-DCI group
(5, 66, and 29 %, respectively). The CTA scan was assessable
to evaluate vasospasm in 67 of the 71 included patients.
Twenty-six of these 67 patients (39 %) had severe vasospasm.
First (experienced) observer
For diagnosing DCI with the delay-sensitive algorithm, the
sensitivity was 0.73, specificity 0.67, PPV 0.67, and NPV






Women (n, %) 26 (79 %) 30 (79 %)
Age (mean, range) 54.7 (28–81) 60.9 (39–80)
Admission WFNS score (%)
I 11 (33 %) 13 (34 %)
II 10 (30 %) 9 (24 %)
III 3 (9 %) 2 (5 %)
IV 5 (15 %) 11 (29 %)





15 (46 %) 10 (26 %)
Anterior cerebral
artery
1 (3 %) 2 (5 %)
Middle cerebral
artery




7 (21 %) 6 (16 %)
Basilar artery 5 (15 %) 7 (18 %)
Internal carotid
artery
5 (15 %) 4 (11 %)
Treatment (%)
Coil 19 (58 %) 12 (32 %)
Clip 12 (36 %) 24 (63 %)
None 1 (3 %) 2 (5 %)
Both 1 (3 %) 0 (0 %)
Vasospasm (%)
CTA not assessable 1 (3 %) 3 (8 %)
None (0–25 %) 8 (24 %) 17 (45 %)
Moderate (25–
50 %)
6 (18 %) 10 (26 %)
Severe (>50 %) 18 (55 %) 8 (21 %)
DCI delayed cerebral ischemia, aSAH aneurysmal subarachnoid hemor-
rhage, n number, WFNS World Federation of Neurological Surgeons,
CTA CT angiography
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0.73. Using the delay-insensitive algorithm, the sensitivity
was 0.72, specificity 0.68, PPV 0.66, and NPV 0.74
(Table 2). For the delay-sensitive algorithm, there were 24
patients with true-positive perfusion deficits (a positive find-
ing on CTP in patients with a diagnosis of clinical deteriora-
tion due to DCI). These perfusion deficits were mostly seen on
MTT (24 patients, 100 %), followed by TTP (22 patients,
92 %), CBF (12 patients, 50 %), and CBV (10 patients,
42 %). Of the 23 patients with true-positive perfusion deficits
on the delay-insensitive algorithm, most deficits were seen on
MTT (19 patients, 83 %), followed by TTP (18 patients,
78 %), CBF (17 patients, 74 %), and CBV (14 patients,
61 %). Figure 1 shows an example of a perfusion deficit for
both the delay-sensitive and delay-insensitive algorithms.
Second (less experienced) observer
For diagnosing DCI with the delay-sensitive algorithm, the
sensitivity was 0.64, specificity 0.62, PPV 0.60, and NPV
0.66. For the delay-insensitive algorithm, the sensitivity was
0.55, specificity 0.68, PPV 0.60, and NPV 0.63 (Table 2). Of
the 21 patients with true-positive perfusion deficits seen on the
delay-sensitive algorithm, most were visible on MTT (20 pa-
tients, 95%), thereafter on TTP (19 patients, 90%), on CBF (7
patients, 33%), and on CBV (4 patients, 19 %). For the delay-
insensitive algorithm, there were 18 patients with true-positive
perfusion deficits, which were seen on MTT and TTP in 18
patients (100 %), on CBF in 6 patients (33 %), and on CBV in
4 patients (22 %).
Subgroup analysis: patients with severe vasospasm on CTA
In the analysis including only patients with severe vasospasm
(n=26), sensitivity, specificity, PPV, and NPV also did not
significantly differ between the tracer delay-sensitive and trac-
er delay-insensitive algorithms (Table 3).
Discussion
Test characteristics for diagnosing DCI by means of visual
CTP assessment are comparable for tracer delay-sensitive
and tracer delay-insensitive CTP algorithms. This applies to
both sensitivity and specificity as well as PPVand NPV.
To our knowledge, no other studies have compared tracer
delay-sensitive and tracer delay-insensitive CTP algorithms in
diagnosing DCI in aSAH patients. A study in ten patients with
thromboembolic stroke found that in visual CTP assessment
tracer delay-sensitive algorithms overestimated the final in-
farct area, while tracer delay-insensitive algorithms correlated
well with the final infarct area [7]. Another study in 20 patients
with unilateral steno-occlusive lesions described the correla-
tion between different CTP parameters (both quantitative and
semiquantitative) and single photon emission computed to-
mography (SPECT) and found that tracer delay-insensitive
CTP algorithms were superior compared to tracer delay-
sensitive algorithms for reliable assessment of perfusion ab-
normalities [13]. Our results in patients with aSAH are in
contrast with these two previous studies in patients with ische-
mic stroke or steno-occlusive disease. An explanation might
be that the delay or dispersion caused by vasospasm is not
comparable to that of steno-occlusive disease or thromboem-
bolic stroke, and only complete occlusion or stenosis >70 %
leads to differences between tracer delay-sensitive and tracer
delay-insensitive CTP algorithms. This is in concordance with
Table 2 Test characteristics of visual CT perfusion assessment for diagnosing DCI
Tracer delay Sensitivity (95 % CI) Specificity (95 % CI) PPV (95 % CI) NPV (95 % CI)
Observer 1 (experienced) Sensitivea 0.73 (0.55–0.87) 0.67 (0.49–0.81) 0.67 (0.49–0.81) 0.73 (0.55–0.87)
Insensitiveb 0.72 (0.53–0.86) 0.68 (0.50–0.82) 0.66 (0.48–0.81) 0.74 (0.56–0.87)
Observer 2 (less experienced) Sensitivea 0.64 (0.45–0.80) 0.62 (0.45–0.78) 0.60 (0.42–0.76) 0.66 (0.48–0.81)
Insensitiveb 0.55 (0.36–0.72) 0.68 (0.50–0.82) 0.60 (0.41–0.77) 0.63 (0.46–0.77)
DCI delayed cerebral ischemia, 95% CI 95 % confidence interval, PPV positive predictive value, NPV negative predictive value
a Tracer delay sensitive is first moment mean transit time (fMTT)
b Tracer delay insensitive is block-circulant singular value decomposition (bSVD)
Fig. 1 Example of a perfusion deficit on CBF maps in the right frontal
lobe in an aSAH patient with DCI. Although the quantitative values are
different for the delay-sensitive (left) and delay-insensitive (right)
algorithms, the size of the lesion is similar
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a phantom model study which found that only a stenosis of
≥70 % resulted in a decreased outflow [14]. However, the
subgroup analysis we performed in patients with severe vaso-
spasm also did not show a difference between the delay-
sensitive and delay-insensitive algorithms. This may be due
the small number of patients in this analysis. Another reason
could be that the difference in perfusion values between the
two CTP algorithms is too small to be visually detected in the
setting of DCI in aSAH patients.
We found somewhat lower test characteristics in this study
compared to the test characteristics in other studies on visual
CTP assessment for evaluation of DCI [1–3, 15]. In the liter-
ature, sensitivity for visual CTP assessment varies from 80 to
84 % and specificity varies from 67 to 83 % [1–3, 15]. This
difference might partially be explained by the fact that in our
study the evaluation of CTP was blinded for the scans that
were performed earlier during admission, whereas in clinical
practice all previous scans are often used in the diagnostic
process. In our study, a total of five patients showed a false-
positive perfusion abnormality. However, when evaluating the
imaging studies performed prior to the clinical deterioration, a
pre-existing infarction was already visible in the region falsely
identified as a DCI-related perfusion deficit in all five patients.
In clinical practice, earlier imaging studies are usually avail-
able when evaluating the presence of DCI on the CTP, and this
allows discrimination of new ischemic lesions from pre-
existing lesions.
In this study, the experienced observer showed a better
visual discriminative performance compared to the less expe-
rienced observer. A plausible explanation could be that there is
a learning curve for the visual assessment of DCI on CTP.
Besides DCI, hydrocephalus, edema, intracerebral hemor-
rhage, or craniotomy can also cause perfusion deficits. This
implies that training is necessary to interpret CTP in patients
with suspected DCI. CTP interpretation could also be im-
proved by a standardized method to determine DCI with
CTP as well as better definitions of perfusion thresholds to
differentiate between patients with DCI and patients without
DCI [1].
A potential limitation of this study is that the diagnosis of
clinical deterioration due to DCI is a diagnosis per
exclusionem and subject to some misclassification. The diag-
nosis of clinical deterioration due to DCI is currently based on
a decrease in the level of consciousness or the development of
focal neurological deficits, after exclusion of other causes for
the clinical deterioration. We used a definition recently pro-
posed by an international multidisciplinary research group as
the reference standard [9]. Although this is a widely adopted
definition for DCI, the chance for some misclassification re-
mains. However, because this is a random misclassification,
the impact on the difference between the two algorithms will
be limited.
The comparable test characteristics we found for tracer
delay-sensitive and tracer delay-insensitive CTP algorithms
in differentiating DCI patients from patients with other causes
of deterioration indicates that both algorithms can be used for
qualitative analysis in patients with aSAH. Because of the
superiority of the time-insensitive perfusion algorithm in
steno-occlusive stroke patients, it is likely that this algorithm
will be implemented in the future. Our results show that im-
plementation of this algorithm has no negative effects if used
for patients with DCI. Our results also imply that the findings
of previous studies studyingDCIwith delay-sensitive CTP are
still generalizable and useful without an increased rate of
false-positive results. The difference found between the two
observers in the visual assessment of CTP implies that further
research on the quality of CTP evaluation by observers with
different levels of experience is needed.
To conclude, tracer delay-sensitive and tracer delay-
insensitive CTP algorithms have similar test characteristics
for the differentiation of aSAH patients with DCI from aSAH
patients with other causes of deterioration. Both algorithms
can therefore be used for qualitative evaluation of DCI in
patients with aSAH.
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Table 3 Test characteristics of visual CT perfusion assessment for diagnosing DCI in patients with severe vasospasm (n=26)
Tracer delay Sensitivity (95 % CI) Specificity (95 % CI) PPV (95 % CI) NPV (95 % CI)
Observer 1 (experienced) Sensitivea 0.94 (0.73 to 1.00) 0.50 (0.16 to 0.84) 0.81 (0.58 to 0.95) 0.80 (0.28 to 1.00)
Insensitiveb 0.82 (0.57 to 0.96) 0.50 (0.16 to 0.84) 0.78 (0.52 to 0.94) 0.57 (0.18 to 0.90)
Observer 2 (less experienced) Sensitivea 0.78 (0.52 to 0.94) 0.38 (0.09 to 0.76) 0.74 (0.49 to 0.91) 0.43 (0.10 to 0.82)
Insensitiveb 0.78 (0.52 to 0.94) 0.43 (0.10 to 0.82) 0.78 (0.52 to 0.94) 0.43 (0.10 to 0.82)
DCI delayed cerebral ischemia, 95% CI 95 % confidence interval, PPV positive predictive value, NPV negative predictive value
a Tracer delay sensitive is first moment mean transit time (fMTT)
b Tracer delay insensitive is block-circulant singular value decomposition (bSVD)
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